285 related articles for article (PubMed ID: 11268459)
1. Relationship between doxorubicin binding ability and tumor volume decrease after chemotherapy in adult malignant soft tissue tumors in the extremities.
Kusuzaki K; Shinjo H; Murata H; Takeshita H; Hashiguchi S; Nozaki T; Emoto K; Ashihara T; Hirasawa Y
Anticancer Res; 2000; 20(5C):3813-6. PubMed ID: 11268459
[TBL] [Abstract][Full Text] [Related]
2. Caffeine-potentiated chemotherapy and conservative surgery for high-grade soft-tissue sarcoma.
Tsuchiya H; Tomita K; Yamamoto N; Mori Y; Asada N
Anticancer Res; 1998; 18(5B):3651-6. PubMed ID: 9854472
[TBL] [Abstract][Full Text] [Related]
3. Assessment of chemosensitivity in patients with malignant bone and soft tissue tumors using thallium-201 scintigraphy and doxorubicin binding assay.
Murata H; Kusuzaki K; Takeshita H; Hirata M; Hashiguchi S; Emoto K; Ashihara T; Hirasawa Y
Anticancer Res; 2000; 20(5C):3967-70. PubMed ID: 11268485
[TBL] [Abstract][Full Text] [Related]
4. [Chemotherapy for pulmonary metastases of soft tissue sarcoma].
Kito M; Umeda T
Gan To Kagaku Ryoho; 1998 Sep; 25(11):1701-6. PubMed ID: 9757195
[TBL] [Abstract][Full Text] [Related]
5. Acquisition of multidrug resistance in osteosarcomas, analyzed by doxorubicin binding assay, and histologic response to chemotherapy.
Kusuzaki K; Hirata M; Hashiguchi S; Takeshita H; Murata H; Ashihara T; Hirasawa Y
Anticancer Res; 1999; 19(6B):5159-62. PubMed ID: 10697527
[TBL] [Abstract][Full Text] [Related]
6. Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients.
Karavasilis V; Seddon BM; Ashley S; Al-Muderis O; Fisher C; Judson I
Cancer; 2008 Apr; 112(7):1585-91. PubMed ID: 18278813
[TBL] [Abstract][Full Text] [Related]
7. Preoperative isolated limb infusion of Doxorubicin and external irradiation for limb-threatening soft tissue sarcomas.
Hegazy MA; Kotb SZ; Sakr H; El Dosoky E; Amer T; Hegazi RA; Farouk O
Ann Surg Oncol; 2007 Feb; 14(2):568-76. PubMed ID: 17094027
[TBL] [Abstract][Full Text] [Related]
8. Caffeine-potentiated radiochemotherapy and function-saving surgery for high-grade soft tissue sarcoma.
Tsuchiya H; Yamamoto N; Asada N; Terasaki T; Kanazawa Y; Takanaka T; Nishijima H; Tomita K
Anticancer Res; 2000; 20(3B):2137-43. PubMed ID: 10928167
[TBL] [Abstract][Full Text] [Related]
9. [Preoperative adjuvant therapy for primary malignant bone tumors].
Goto T; Okuma T; Nakada I; Hozumi T; Kondo T
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1750-4. PubMed ID: 18030009
[TBL] [Abstract][Full Text] [Related]
10. Analysis of prognostic factors and chemotherapy of malignant fibrous histiocytoma of soft tissue: a preliminary report.
Shinjo K
Jpn J Clin Oncol; 1994 Jun; 24(3):154-9. PubMed ID: 8007425
[TBL] [Abstract][Full Text] [Related]
11. [Histological changes after chemotherapy of soft tissue sarcomas in the adult].
Coindre JM; Nguyen BB; Goussot JF; de Mascarel I; Maree D; de Mascarel A; Trojani M
Ann Pathol; 1985; 5(2):95-9. PubMed ID: 3840024
[TBL] [Abstract][Full Text] [Related]
12. Decrease in tumor volume and histologic response to intraarterial neoadjuvant chemotherapy in patients with cervical and endometrial adenocarcinoma.
Fujiwaki R; Takahashi K; Kitao M
Gynecol Oncol; 1997 May; 65(2):258-64. PubMed ID: 9159335
[TBL] [Abstract][Full Text] [Related]
13. [Clinical studies on preoperative continuous intra-arterial chemotherapy in the treatment of malignant soft tissue tumors].
Sato M; Takeuchi S; Kasai C; Kushida Y; Matsunaga T
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1754-9. PubMed ID: 1908651
[TBL] [Abstract][Full Text] [Related]
14. Histologic alterations from neoadjuvant chemotherapy in high-grade extremity soft tissue sarcoma: clinicopathological correlation.
Lucas DR; Kshirsagar MP; Biermann JS; Hamre MR; Thomas DG; Schuetze SM; Baker LH
Oncologist; 2008 Apr; 13(4):451-8. PubMed ID: 18448561
[TBL] [Abstract][Full Text] [Related]
15. [Bone and soft-tissue tumors].
Shirai Y; Nakase T
Gan To Kagaku Ryoho; 1986 Jan; 13(1):30-6. PubMed ID: 3002285
[TBL] [Abstract][Full Text] [Related]
16. [Application of preoperative chemotherapy to postoperative chemotherapy in malignant bone and soft tissue tumors].
Furuse K; Morimoto K; Yamamoto K; Orito T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1749-54. PubMed ID: 2730070
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy for soft tissue sarcomas.
Ravi V; Patel S
Surg Oncol Clin N Am; 2012 Apr; 21(2):243-53. PubMed ID: 22365517
[TBL] [Abstract][Full Text] [Related]
18. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy of soft tissue tumors].
Obrecht JP; Ludwig R
Orthopade; 1988 Apr; 17(2):201-8. PubMed ID: 3290801
[TBL] [Abstract][Full Text] [Related]
20. [Pilot study of an alternative CYVADIC + CBDCA protocol for adult soft tissue sarcoma as adjuvant chemotherapy].
Matsumoto S; Kawaguchi N; Manabe J; Matsushita Y; Tanizawa T
Gan To Kagaku Ryoho; 2002 Sep; 29(9):1571-4. PubMed ID: 12355942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
